Although migraine and stroke are dis nct diseases, there is increasing evidence for comorbidity and overlapping pathology. 1,2 Epidemiological studies have suggested that the link is more pronounced for migraine with aura, 3 a migraine...
moreAlthough migraine and stroke are dis nct diseases, there is increasing evidence for comorbidity and overlapping pathology. 1,2 Epidemiological studies have suggested that the link is more pronounced for migraine with aura, 3 a migraine subtype in which the headache is preceded by transient focal neurological symptoms ("aura"). 4 Human imaging and animal studies have indicated that cor cal spreading depolariza on (CSD), a wave of massive depolariza on of neurons and glial cells that is accompanied by vasodilata on due to neurovascular coupling, 1 is the mechanism underlying the migraine aura. 5,6 Waves with similar characteris cs also occur in ischemic stroke, where they are referred to as peri-infarct depolariza ons (PIDs). 7,8 PIDs circle around the ischemic core, into the border zone ("penumbra") thereby increasing the ischemic territory with each wave, due to, amongst others, paradoxical vasoconstric on and accompanying supply-demand mismatch. 7,8 It has therefore been postulated that spreading depolariza on (SD), with involvement of neuronal and vascular mechanisms, may explain the link between migraine and stroke. 1 The rela on between migraine and stroke is also refl ected in the clinical spectrum of various monogenic diseases. 9 We envisaged that inves ga ng transgenic mouse models for such disorders, and comparing measures of migraine (i.e. CSD) and stroke (i.e. ischemia a er transient middle cerebral artery occlusion (MCAO)) in them, may shed light on the mechanisms relevant to migraine and stroke. Here we used mouse models for three disorders for which the rela on between migraine and stroke (in pa ents and/or in animal studies) is most pronounced: Familial Hemiplegic Migraine type 1 (FHM1), 10 Cerebral Autosomal Dominant Arteriopathy with Subcor cal Infarcts and Leukoencephalopathy (CADASIL), 11 and Re nal Vasculopathy with Cerebral Leukoencephalopathy and Systemic manifesta ons (RVCL-S). 12 FHM1 is a monogenic form of migraine caused by specifi c missense muta ons in CACNA1A that result in a acks of headache accompanied by an aura with hemiparesis. 4,13 FHM1 exhibits a neuronal phenotype as shown by the enhanced neurotransmission and increased suscep bility to CSD in FHM1 mutant mice. 14-16 FHM1 mice, either with the R192Q or the S218L muta on, were shown to also have an increased vulnerability to ischemic stroke, as evidenced by the increased infarct volume and decreased anoxic depolariza on (AD) latency. 17 Of note, a follow-up study only confi rmed the infarct volume phenotype in the severer S218L mutant mice. 18 CADASIL is a progressive small vessel disease caused by muta ons involving cysteines in NOTCH3 that result in ischemic strokes and (vascular) demen a. 19,20 Notably, the presen ng symptom of CADASIL in 40% of pa ents is migraine with aura. 21,22 CADASIL exhibits a vascular phenotype as evidenced by an accumula on of mutant protein in vascular smooth muscle cells in a transgenic overexpressor mouse model for CADASIL. 23,24 Of note, another CADASIL mouse model expressing a diff erent NOTCH3 muta on also showed hallmarks of CADASIL, and interes ngly, also an increased suscep bility for CSDs. 25 Finally, RVCL-S, which is caused by C-terminal trunca ng muta ons in TREX1 that cause systemic microvascular vasculopathy with white ma er lesions. 26 Many pa ents with RVCL-S also have migraine. 26 RVCL-S exhibits a vascular (endothelial) phenotype but the exact mechanism that results in pathology is not known. An unpublished knock-in (KI) mouse model that expresses truncated Trex1 protein was generated and analyzed in the present study. Given that disease onset in pa ents with CADASIL 27-29 and with RVCL-S 12 typically occurs at middle age, but at rela vely young age in pa ents with FHM, 10 we compared readouts for migraine and ischemic stroke in young (3-to 6-month-old; both CSD and ischemic stroke) and old (12-to 14-month old; only ischemic stroke) FHM1, CADASIL and RVCL-S mice and the